Anti-Endothelial Cell Antibodies are not frequently elevated in hospitalized patients with COVID-19

Anti-Endothelial Cell Antibodies are not frequently elevated in hospitalized patients with COVID-19

Authors

  • Brandon Henry a:1:{s:5:"en_US";s:45:"Cincinnati Children's Hospital Medical Center";}
  • Stefanie Benoit Division of Nephrology and Hypertension, Cincinnati Children’s Hospital Medical Center, OH, USA
  • Jens Vikse Clinical Immunology Unit, Stavanger University Hospital, Stavanger, Norway
  • Emmanuel Favaloro Haematology, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead NSW, Australia
  • Justin Benoit Department of Emergency Medicine, University of Cincinnati, Cincinnati, OH, USA
  • Giuseppe Lippi Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy
DOI: https://doi.org/10.23750/abm.v93i2.11196

Keywords:

SARS-CoV-2, auto-antibodies, coagulopathy

Abstract

n/a

References

[1] Lippi G, Sanchis-Gomar F, Henry BM. COVID-19: unravelling the clinical progression of nature’s virtually perfect biological weapon. AnnTrans Med. 2020;8:693.
[2] Henry BM, Vikse J, Benoit S, et al. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clinica Chimica Acta. 2020;507:167–173.
[3] Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med 2020;382:e38.
[4] Bowles L, Platton S, Yartey N, et al. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19. N Engl J Med. 2020;383:288–290.
[5] Harzallah I, Debliquis A, Drénou B. Lupus anticoagulant is frequent in patients with Covid-19. J Thromb Haemost. 2020;
[6] Galeano-Valle F, Oblitas CM, Ferreiro-Mazón MM, et al. Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism. Thromb Res. 2020;192:113–115.
[7] Alessandri C, Bombardieri M, Valesini G. Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance. Adv Clin Chem. 2006;42:297–326.
[8] Praprotnik S, Blank M, Meroni PL, et al. Classification of anti–endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: The pathogenic and diagnostic implications. Arthritis & Rheumatism. 2001;44:1484–1494.
[9] Yang Y, Huang Y, Chuang Y, et al. Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)‐associated coronavirus infection. J Med Virol. 2005;77:1–7.
[10] Belizna C, Duijvestijn A, Hamidou M, et al. Antiendothelial cell antibodies in vasculitis and connective tissue disease. Ann Rheum Dis. 2006;65:1545–1550.

 

Downloads

Published

11-05-2022

Issue

Vol. 93 No. 2 (2022)

Section

REVIEWS/FOCUS ON - SPECIAL COVID19

License

Copyright (c) 2022 Brandon Henry, Stefanie Benoit, Jens Vikse, Emmanuel Favaloro, Justin Benoit, Giuseppe Lippi

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. 
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

How to Cite

1.
Henry B, Benoit S, Vikse J, Favaloro E, Benoit J, Lippi G. Anti-Endothelial Cell Antibodies are not frequently elevated in hospitalized patients with COVID-19. Acta Biomed [Internet]. 2022 May 11 [cited 2024 Jul. 17];93(2):e2022043. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/11196
Crossref
Scopus
Google Scholar
Europe PMC